Xu F Y, Kelly S L, Hatch G M
Department of Pharmacology and Therapeutics, University of Manitoba, 770 Bannatyne Avenue, Winnipeg, Manitoba, Canada R3E OW3.
Biochem J. 1999 Feb 1;337 ( Pt 3)(Pt 3):483-90.
Cardiolipin and phosphatidylglycerol biosynthesis were examined in H9c2 cells incubated with short-chain ceramides. Incubation of cells with N-acetylsphingosine or N-hexanoylsphingosine stimulated [1, 3-3H]glycerol incorporation into phosphatidylglycerol and cardiolipin, with N-acetylsphingosine having the greater effect. The mechanism for the ceramide-mediated stimulation of de novo phosphatidylglycerol and cardiolipin biosynthesis appeared to be an increase in the activity of phosphatidylglycerolphosphate synthase, the committed step of phosphatidylglycerol and cardiolipin biosynthesis. The presence of the potent protein phosphatase inhibitors calyculin A or okadaic acid attenuated the N-acetylsphingosine-mediated stimulation of phosphatidylglycerolphosphate synthase activity and of phosphatidylglycerol and cardiolipin biosynthesis, indicating the involvement of a ceramide-activated protein phosphatase(s). The presence of 8-(4-chlorophenylthio)-cAMP (CPT-cAMP) stimulated enzyme activity and [1,3-3H]glycerol incorporation into phosphatidylglycerol and cardiolipin. The effects of CPT-cAMP and N-acetylsphingosine on phosphatidylglycerol and cardiolipin biosynthesis and on phosphatidylglycerolphosphate synthase activity were additive. Phosphatidylglycerol biosynthesis from sn-[14C]glycerol 3-phosphate in permeabilized H9c2 cells was stimulated by preincubation with N-acetylsphingosine, and this was attenuated by okadaic acid. N-Acetylsphingosine treatment of cells elevated mitochondrial phospholipase A2 activity. Since the pool sizes of phosphatidylglycerol and cardiolipin were unaltered in these cells, the observed increase in phosphatidylglycerolphosphate synthase activity may be a compensatory mechanism for the N-acetylsphingosine-mediated elevation of mitochondrial phospholipase A2 activity. Finally, addition of tumour necrosis factor alpha to H9c2 cells resulted in an elevation of both phosphatidylglycerolphosphate synthase and phospholipase A2 activities. The results suggest that phosphatidylglycerol and cardiolipin metabolism in H9c2 cells may be regulated by intracellular ceramide signalling.
在与短链神经酰胺孵育的H9c2细胞中检测了心磷脂和磷脂酰甘油的生物合成。用N - 乙酰鞘氨醇或N - 己酰鞘氨醇孵育细胞刺激了[1,3 - 3H]甘油掺入磷脂酰甘油和心磷脂,其中N - 乙酰鞘氨醇的作用更强。神经酰胺介导的从头合成磷脂酰甘油和心磷脂生物合成的刺激机制似乎是磷脂酰甘油磷酸合酶活性增加,这是磷脂酰甘油和心磷脂生物合成的关键步骤。强效蛋白磷酸酶抑制剂calyculin A或冈田酸的存在减弱了N - 乙酰鞘氨醇介导的磷脂酰甘油磷酸合酶活性以及磷脂酰甘油和心磷脂生物合成的刺激,表明存在神经酰胺激活的蛋白磷酸酶。8 -(4 - 氯苯基硫代)-cAMP(CPT - cAMP)的存在刺激了酶活性以及[1,3 - 3H]甘油掺入磷脂酰甘油和心磷脂。CPT - cAMP和N - 乙酰鞘氨醇对磷脂酰甘油和心磷脂生物合成以及磷脂酰甘油磷酸合酶活性的影响是相加的。用N - 乙酰鞘氨醇预孵育可刺激透化的H9c2细胞中由sn - [14C]甘油3 - 磷酸合成磷脂酰甘油,而冈田酸可减弱这种刺激。用N - 乙酰鞘氨醇处理细胞可提高线粒体磷脂酶A2活性。由于这些细胞中磷脂酰甘油和心磷脂的库大小未改变,观察到的磷脂酰甘油磷酸合酶活性增加可能是N - 乙酰鞘氨醇介导的线粒体磷脂酶A2活性升高的一种补偿机制。最后,向H9c2细胞中添加肿瘤坏死因子α导致磷脂酰甘油磷酸合酶和磷脂酶A2活性均升高。结果表明,H9c2细胞中的磷脂酰甘油和心磷脂代谢可能受细胞内神经酰胺信号调节。